These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 8972475

  • 21. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
    Takigawa N, Ida M, Segawa Y, Nakata M, Mandai K, Kishino D, Fujiwara K, Saeki H, Takashima S, Eguchi K.
    Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
    [Abstract] [Full Text] [Related]

  • 22. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.
    Mori M, Chiba R, Takahashi T.
    Cancer; 1993 Oct 15; 72(8):2331-40. PubMed ID: 8402446
    [Abstract] [Full Text] [Related]

  • 23. Survivin expression in atypical adenomatous hyperplasia of the lung.
    Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E.
    Am J Clin Pathol; 2003 Nov 15; 120(5):712-9. PubMed ID: 14608897
    [Abstract] [Full Text] [Related]

  • 24. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.
    Blöndal T, Lindgren A.
    Anal Quant Cytol; 1982 Sep 15; 4(3):225-32. PubMed ID: 7149488
    [Abstract] [Full Text] [Related]

  • 25. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
    Xu X, Li N, Zhao R, Zhu L, Shao J, Zhang J.
    J Cancer Res Clin Oncol; 2017 Dec 15; 143(12):2447-2453. PubMed ID: 28821955
    [Abstract] [Full Text] [Related]

  • 26. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
    J Clin Pathol; 2005 Oct 15; 58(10):1076-80. PubMed ID: 16189154
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
    Kohno T, Kakinuma R, Iwasaki M, Yamaji T, Kunitoh H, Suzuki K, Shimada Y, Shiraishi K, Kasuga Y, Hamada GS, Furuta K, Tsuta K, Sakamoto H, Kuchiba A, Yamamoto S, Kanai Y, Tsugane S, Yokota J.
    Carcinogenesis; 2010 Oct 15; 31(10):1794-9. PubMed ID: 20688833
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
    Barletta A, Marzullo F, Pellecchia A, Montemurro S, Labriola A, Lomonaco R, Grammatica L, Paradiso A.
    Anticancer Res; 1998 Oct 15; 18(3A):1677-82. PubMed ID: 9673389
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
    Selamat SA, Galler JS, Joshi AD, Fyfe MN, Campan M, Siegmund KD, Kerr KM, Laird-Offringa IA.
    PLoS One; 2011 Oct 15; 6(6):e21443. PubMed ID: 21731750
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung.
    Cooper CA, Carby FA, Bubb VJ, Lamb D, Kerr KM, Wyllie AH.
    J Pathol; 1997 Apr 15; 181(4):401-4. PubMed ID: 9196437
    [Abstract] [Full Text] [Related]

  • 39. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?
    Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG.
    Cancer Res; 1998 Feb 01; 58(3):389-91. PubMed ID: 9458077
    [Abstract] [Full Text] [Related]

  • 40. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B, Jaswal TS, Arora B.
    Indian J Cancer; 2004 Feb 01; 41(2):60-5. PubMed ID: 15318010
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.